Atlas Trials

An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC

Clinical trial NCT05327582 · UNKNOWN

Trial details

NCT number
NCT05327582
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerBiliary Tract Cancer
Start date
2022-04-12
Primary completion
2023-04-30
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.